Macquarie Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,506
| Closed | -$70K | – | 2471 |
|
|
2022
Q3 | $70K | Sell |
1,506
-1,262
| -46% | -$58.7K | ﹤0.01% | 1851 |
|
|
2022
Q2 | $84K | Buy |
2,768
+936
| +51% | +$28.4K | ﹤0.01% | 1914 |
|
|
2022
Q1 | $60 | Hold |
1,832
| – | – | ﹤0.01% | 2077 |
|
|
2021
Q4 | $48K | Buy |
1,832
+1,238
| +208% | +$32.4K | ﹤0.01% | 2175 |
|
|
2021
Q3 | $60K | Buy |
594
+223
| +60% | +$22.5K | ﹤0.01% | 2171 |
|
|
2021
Q2 | $53K | Sell |
371
-360
| -49% | -$51.4K | ﹤0.01% | 2150 |
|
|
2021
Q1 | $73K | Sell |
731
-220
| -23% | -$22K | ﹤0.01% | 1988 |
|
|
2020
Q4 | $118K | Sell |
951
-209
| -18% | -$25.9K | ﹤0.01% | 1829 |
|
|
2020
Q3 | $113K | Sell |
1,160
-7,590
| -87% | -$739K | ﹤0.01% | 1749 |
|
|
2020
Q2 | $1.37M | Sell |
8,750
-3,011
| -26% | -$470K | ﹤0.01% | 1124 |
|
|
2020
Q1 | $1.7M | Hold |
11,761
| – | – | ﹤0.01% | 960 |
|
|
2019
Q4 | $2.41M | Buy |
+11,761
| New | +$2.41M | ﹤0.01% | 983 |
|